Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Vagina01:26

Vagina

The vaginal canal is a tubular structure averaging about 10 cm in length that acts as the entryway to the female reproductive system and the passageway for menstrual flow and childbirth. The interior walls of the vagina exhibit concentric folds called rugae and are topped by an area known as the fornix, which connects with the protruding cervical portion of the uterus. This canal is comprised of an external fibrous layer, a muscular middle layer, and an inner lining with mucosal rugae, which...
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-drug conjugates: a practical review on clinical management of toxicities.

Expert review of anticancer therapy·2026
Same author

Clinical relevance and prognostic role of PDL-1 expression in cervical cancer patients.

Archives of gynecology and obstetrics·2026
Same author

Intravaginal progesterone as a fertility-sparing treatment for symptomatic adenomyosis: preliminary results from a monocentric study.

Archives of gynecology and obstetrics·2026
Same author

Outcomes of node-positive cervical cancer treated with neoadjuvant chemotherapy followed by radical surgery: a single-center approach to a challenging disease.

Journal of gynecologic oncology·2026
Same author

The immunological fitness of NSCLC patients drives the response to anti-PD1-based immunotherapy regardless of age.

Journal of translational medicine·2026
Same author

Prophylactic ureteral suturing after ureterolysis in deep endometriosis: description of a conservative laparoscopic technique.

Minerva obstetrics and gynecology·2026

Related Experiment Video

Updated: Jun 2, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Vaginal cancer.

Violante Di Donato1, Filippo Bellati, Margherita Fischetti

  • 1Department of Obstetrics and Gynecology, University of Rome "Sapienza", Viale Del Policlinico 155, 00187 Rome, Italy. violante.didonato@uniroma1.it

Critical Reviews in Oncology/Hematology
|May 17, 2011
PubMed
Summary
This summary is machine-generated.

Treatment for vaginal cancer varies due to its rarity, with surgery and radiotherapy being primary options. Current guidelines rely on retrospective data, leading to diverse therapeutic strategies for this rare gynecologic malignancy.

More Related Videos

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
08:53

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

Related Experiment Videos

Last Updated: Jun 2, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
08:53

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

Area of Science:

  • Gynecologic Oncology
  • Radiation Oncology
  • Surgical Oncology

Background:

  • Vaginal cancer has a low incidence, precluding large-scale Phase III trials.
  • Current treatment guidelines are based on retrospective studies, leading to varied therapeutic approaches.
  • The rarity of vaginal cancer necessitates a review of existing treatment strategies.

Purpose of the Study:

  • To review and report current therapeutic strategies for vaginal cancer.
  • To analyze the outcomes of different treatment modalities across various stages of vaginal carcinoma.
  • To provide insights into the management of this rare gynecologic malignancy.

Main Methods:

  • Review of retrospective studies and current clinical practices for vaginal cancer treatment.
  • Analysis of therapeutic options including surgery, radiotherapy (brachytherapy and EBRT), and chemotherapy.
  • Stratification of treatment strategies based on cancer stage (Stage I, II, III-IV A).

Main Results:

  • Stage I vaginal carcinoma is primarily treated with surgery and/or radiotherapy; wide excision for small tumors and aggressive surgery for high-risk patients.
  • Stage II commonly involves a combination of brachytherapy and external beam radiation therapy (EBRT), with radical surgery as an option for selected patients.
  • Stages III-IV A typically utilize a combination of EBRT and brachytherapy, with pelvic exenteration or combined irradiation and exenteration for selected cases. Neoadjuvant chemotherapy followed by radical surgery is a viable alternative.

Conclusions:

  • Treatment for vaginal cancer is stage-dependent and often involves a multimodal approach.
  • The lack of Phase III trials highlights the need for continued research and standardized treatment protocols.
  • Current therapeutic strategies, including surgery, radiotherapy, and chemotherapy, offer viable options for managing vaginal cancer across different stages.